Language selection

Search

Patent 1095062 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1095062
(21) Application Number: 1095062
(54) English Title: 2,6-METHANO-2H-1-BENZOXOCINS
(54) French Title: 2,6-METHANO-2H-1-BENZOXOCINES
Status: Term Expired - Post Grant
Bibliographic Data
(51) International Patent Classification (IPC):
  • C07D 311/78 (2006.01)
  • C07D 311/80 (2006.01)
  • C07D 313/20 (2006.01)
(72) Inventors :
  • RYAN, CHARLES W. (United States of America)
(73) Owners :
  • ELI LILLY AND COMPANY
(71) Applicants :
  • ELI LILLY AND COMPANY (United States of America)
(74) Agent: GOWLING WLG (CANADA) LLP
(74) Associate agent:
(45) Issued: 1981-02-03
(22) Filed Date: 1978-09-05
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
831,454 (United States of America) 1977-09-08

Abstracts

English Abstract


Abstract of the Disclosure
This invention provides a process for preparing
5-isopropylidene-2,7-dihydroxy-9-substituted-2,6-methano-
3,4,5,6-tetrahydro-2H-1-benzoxocins, which process is char-
acterized by reacting a 5-(substituted)resorcinol with a
1-alkoxy-4-(1-hydroxy-1-methylethyl)-1,4-cyclohexadiene in
the presence of stannic chloride for from 1 to 15 minutes.
The benzoxocin derivatives are useful in the synthesis of
certain dibenzo[b,d]pyran-9-ones, valuable as anti-anxiety,
analgesic, and anti-depressant drugs.
X-4585J


Claims

Note: Claims are shown in the official language in which they were submitted.


What is claimed is:
1. A process for preparing 5-isopropylidene-
2,7-dihydroxy-9-substituted-2,6-methano-3,4,5,6-tetrahydro-
2H-1-benzoxocins of the formula
<IMG>
in which R1 is C5-C10 alkyl, C5-C10 alkenyl, C5-C8 cyclo-
alkyl, or C5-C8 cycloalkenyl; which process is characterized
by reacting a 1-alkoxy-4-(1-hydroxy-1-methylethyl)-1,4-
cyclohexadiene of the formula
<IMG> III
wherein R3 is C1-C4 alkyl, with a 5-substituted resorcinol
of the formula
<IMG> II
in an organic solvent in the presence of stannic chloride
X-4585J-1 -13-

for from 1 to 15 minutes at a temperature from -40°C. to
ambient temperature.
X-4585J-1 -14-

2. The process of claim 1 for preparing a compound
of formula I wherein R1 is C5-C10 alkyl, characterized in
that a compound of formula II wherein R1 is C5-C10 alkyl is
reacted with a compound of formula III.
3. The process of claim 2 characterized in that the
reaction time is from 1 to 10 minutes.
4. The process of claim 3 characterized in that the
process is carried out in a halogenated hydrocarbon solvent.
5. The process of claim 4 characterized in that the
process takes place in the presence of a small amount of
water.
6. The process of claim 5 characterized in that the
reaction temperature is from -20° to 10°C.
7. The process of claim 1 characterized in that the
reaction time is from 1 to 10 minutes.
8. The process of claim 7 characterized in that the
reaction temperature is from -20°C. to 10°C.
9. The process of claim 8 characterized in that the
process is carried out in a halogenated hydrocarbon solvent.
10. The process of claim 9 characterized in that the
process takes place in the presence of a small amount of
water.
11. The process of claim 1 characterized in that the
process is carried out in a halogenated hydrocarbon solvent.
12. The process of claim 11 characterized in that
the process takes place in the presence of a small amount of
water.
13. The process of claim 12 characterized in that
the reaction temperature is from -20°C. to 10°C.
- 15 -

14. The process of claim 13 for preparing a compound
of formula I wherein R1 is C5-C10 alkyl characterized in
that a compound of formula II wherein R1 is C5-C10 alkyl is
reacted with a compound of formula III.
15. The process of claim 1 for preparing 2,7-
dihydroxy-5-isopropylidene-9-(1,1-dimethylheptyl)-2,6-
methano-3,4,5,6-tetrahydro-2H-1-benzoxocin characterized in
that 5-(1,1-dimethylheptyl) resorcinol is reacted with
1-methoxy-4-(1-hydroxy-1-methylethyl)-1,4-cyclohexadiene.
16. The process of claim 15 characterized in that
the reaction time is 1 minute.
17. The process of claim 15 characterized in that
the reaction time is 2-3 minutes.
18. The process of claim 15 characterized in that
the reaction time is 10 minutes.
19. The process of any of claims 16-18 characterized
in that the reaction temperature is from -20°C. to -4°C.
20. The process of any of claims 16-18 characterized
in that the reaction temperature is from -20°C. to -11°C.
21. The process of any of claims 16-18 characterized
in that the reaction temperature is from 0°C. to 10°C.
22. The process of any of claims 16-18 characterized
in that the reaction temperature is from -40°C. to -11°C.
23. The process of any of claims 16-18 characterized
in that the reaction temperature is from -20°C. to 9°C.
- 16 -

24. A compound of formula I as defined in
claim 1, whenever prepared by the process of claim 1 or
by an obvious chemical equivalent thereof.
25. The compound 2,7-dihydroxy-5-isopropylidene
-9-(1,1- dimethylheptyl)-2,6-methano-3,4,5,6-tetrahydro
-2H-1-benzoxocin, whenever prepared by the process of claim 15
or by an obvious chemical equivalent thereof.
26. A compound of formula I as defined in claim 1
wherein R1 is C5-C10 alkyl, whenever prepared by the process
of claim 2 or claim 14 or by an obvious chemical equivalent
thereof.
- 17 -

Description

Note: Descriptions are shown in the official language in which they were submitted.


lO~O~iZ
This invention provides a process for preparing
5-isopropylidene-2,7-dihydroxy-9-substituted-2,6-methano-
3,4,5,6-tetrahydro-2H-l-benzoxocins, which process is char-
acterized by reacting a 5-(substituted)resorcinol with a
1-alkoxy-4-(1-hydroxy-1-methylethyl)-1,4-cyclohexadiene in
the presence of stannic chloride for from 1 to 15 minutes.
The benzoxocin derivatives are useful in the synthesis of
certain dibenzo[b,d]pyran-9-ones, valuable as anti-anxiety,
analgesic, and anti-depressant drugs.
The present invention pertains to 5-isopropylidene-
2,7-dihydroxy-9-substituted-2,6-methano-3,4,5,6-tetrahydro-
2H-l-benzoxocins. Certain benzoxocin derivatives are known
in the art. 2-Methyl-5-isopropenyl-7-hydroxy-9-n-pentyl-
2,6-methano-3,4,5,6-tetrahydro-2H-l-benzoxocin has been
prepared by reaction of boron trifluoride etherate with
2-(3-methyl-6-isopropenyl-2-cyclohexenyl)-5-n-pentylresorcinol,
commonly referred to as cannabidiol; see Gaoni and Mechoulam,
Tetrahedron, 22, 1481 (1966), and J. Am. Chem. Soc., 93, 217
(1971). Razdan and Zitko reported that the above named
isopropenyl benzoxocin derivative can be converted to the
corresponding isopropylidene benzoxocin derivative by
reaction with ~-toluenesulfonic acid. These authors addi-
tionally suggested that 2-methyl-5-isopropylidene-7-
hydroxy-9-n-pentyl-2,6-methano-3,4,5,6-tetrahydro-2H-l-
benzoxocin can be converted to l-hydroxy-3-_-pentyl-
6,6,9-trimethyl-6a,7,8,10a-tetrahydrodibenzo[b,d]pyran under
acidic conditions; see Tetrahedron Letters, No. 56, 4947
(1969). Recently, Razdan et al. reported the preparation of
X-4585

" 109S062
2-methyl-5-isoprop~iidene-7-nydroxy-9-n-pentyl-2,6-methano-
3,4,5,6-tetrahydro-2H-l-benzoxocin by reaction of 5-~-
pentylresorcinol with l-hydroxy-l-methyl-4-isopropenyl-2-
cyclohexene; J. Am. Chem. Soc~, 96, 5860 (1974).
The compounds described by formula I below have
been described before, such as in Belgian Patent 856,409.
In that patent it is explained that the compounds of formula
I are useful as intermediates for the preparation of dibenzo-
[b,d]pyran-9-ones, which are now known to be of great
importance as antl-depressant and anti-anxiety drugs. This
invention provides a particularly ~uick and efficient
process for preparing such intermediate benzoxocins.
The present invention provides a process for
preparing 5-isopropylidene-2,7-dihydroxy-9-substituted-
2,6-methano-3,4,5,6-tetrahydro-2H-l-benzoxocins of the
formula
CH3
H3C--~ ~H
/5 /~
2 o I CH~ 0 L
o
OH
1 C5 C10 alkyl, C5-C10 alkenyl, C5-C cyclo-
alkyl, or C5-C8 cycloalkenyl; which process is characterized
by reacting a l-alkoxy-4-(1-hydroxy-1-methylethyl)-1,4-
cyclohexadiene of the formula
X-4585J ~3~
X~

~L09~6~:
10-R3
I I III
~/
HO - C - CH
CH3
wherein R3 is Cl-C4 alkyl, with a 5-substituted resorcinol
of the formula
Il()\ ~ ~ /OH
I ~ II
~t/
~,
in an organic solvent in the presence of stannic chloride
for from 1 to 15 minutes at a temperature from -40C. to
ambient temperature.
Any of a number of 5-substituted resorcinols can
be utilized in the condensation, in which the 5-substituent
of the resorcinol is defined by Rl in the above formula.
Representative examples of C5-C10 alkyl groups include
n-pentyl, n-hexyl, l-methylpentyl, isoheptyl, l,l-dimethyl-
heptyl, 1,2,3-trimethylheptyl, isodecyl, l-ethylheptyl,
l,l-diethylpentyl and 1,2-dimethyloctyl.
Examples of C5-C10 alkenyl groups include 2-
pentenyl, 3-hexenyl, 1,2-dimethyl-1-heptenyl, 4-octenyl,
1,1-dimethyl-2-heptenyl, 1-ethyl-2-methyl-2-pentenyl,
1,2,3-trimethyl-3-heptenyl, and related groups.
X-4585J -4-

~ ~950~2
Typical C5-C8 cycloalkyl groups include cyclo-
pentyl, cyclohexyl, cycloheptyl and cyclooctyl. Similarly,
typical C5-C8 cycloalkenyl groups include 1-cyclopentenyl,
2-cyclohexenyl, 3-cyclohexenyl, l-cycloheptenyl, and 1-
cyclooctenyl.
Examples of 5-substituted resorcinols of formula
II routinely reacted with the aforementioned l-alkoxy-
4-(1-hydroxy-1-methylethyl)-1,4-cyclohexadiene to provide
the compounds of formula r include 5-_-pentylresorcinol,
5-(1,1-dimethylheptyl)resorcinol, 5-(1,2-dimethyl-1-hept-
enyl)resorcinol, 5-(1-ethylhexyl)resorcinol, 5-(3-hexenyl)-
resorcinol, 5-cycloheptylresorcinol, 5-cyclooctylresorcinol,
5-(1-cyclohexenyl)resorcinol, 5-(2-cycloheptenyl)resorcinol,
and related resorcinols.
In accordance with this invention, approximately
equimolar quantities of a 5-substituted resorcinol and a 1-
alkoxy-4-(1-hydroxy-1-methylethyl)-1,4-cyclohexadiene are
commingled in the presence of stannic chloride and in an
organic solvent, at a temperature generally from -40C. to
ambient temperature.
The above-described reactions to prepare compounds
of formula I are carried out in an organic solvent. Commonly
used solvents include halogenated hydrocarbons such as
dichloromethane, chloroform, l,l-dichloroethane, 1,2-
dichloroethane, bromomethane, 1,2-dibromoethane, l-bromo-
2-chloroethane, l-bromopropane, l,l-dibromoethane, 2-
chloropropane, l-iodopropane, 1-bromo-2-chloroethane,
bromobenzene, and 1,2-dichlorobenzene; and aromatic solvents
such as benzene~ chlorobenzene, toluene, and xylene.
X-4585J -5-

1~950G2
Small amounts of water in the reaction mixture
tend to improve the process, and the addition of water is a
preferred technique. The preferred amount of water is about
one mole per mole of product to be prepared.
The process of this invention is complete in very
short reaction times from 1 to 15 minutes. The preferred
reaction time is from 1 to 10 minutes. As is made clear by
the following examples, it is desirable to carry out this
process very quickly, and to quench the reaction mixture as
soon as the additions are complete.
The preferred method for carrying out the process
of this invention is to to combine the compounds of formulae
II and III, to cool the reaction mixture to relatively low
temperature toward the bottom of the temperature range, and
to then add the stannic chloride in a fine stream or
dropwise over a period of a few minutes, allowing the
reaction mixture to warm somewhat as the addition is carried
on.
Of course, the reaction will commence as soon as
the compounds of formulae II and III and the catalyst are
all present in the reaction mixture. Accordingly, the order
of addition may be any which may be convenient in the
circumstances, so long as the temperature is controlled
during the addition of the last item to the reaction
mixture, and so long as the reaction is properly quenched
so that the period of time during which all of the necessary
ingredients are present in the reaction mixture does not
exceed the specified time periods.
X-4585J -6~
....

S0~2
Upon completion of the reaction, isolation of the
benzoxocin derivative normally is a simple procedure and can
usually be accomplished by washing the reaction mixture with
water and a dilute aqueous base, evaporating the reaction
solvent, and crystallizing the residual product from common,
relatively nonpolar solvents such as hexane or methylcyclo-
hexane.
Examples of typical benzoxocins of formula I which
can routinely be prepared and which are provided in accord-
ance with the present invention are as follows:
2,7-dihydroxy-5-isopropylidene-9-n-pentyl-2,6-
methano-3,4,5,6-tetrahydro-2H-l-benzoxocin;
2,7-dihydroxy-5-isopropylidene-9-(1,2-dimethyl-
heptyl)-2,6-methano-3,4,5,6-tetrahydro-2H-l-benzoxocin;
2,7-dihydroxy-5-isopropylidene-9-(2-hexenyl)-
2,6-methano-3,4,5,6-tetrahydro-2H-l-benzoxocin;
2,7-dihydroxy-5-isopropylidene-9-(1-ethyl-2-
methyl-2-butenyl) 2,6-methano-3,4,5,6-tetrahydro-2H-l-
benzoxocin;
202,7-dihydroxy-5-isopropylidene-9-cyclohexyl-
2,6-methano-3,4,5,6-tetrahydro-2H-l-benzoxocin;
2,7-dihydroxy-5-isopropylidene-9-(n-decyl)-2,6-
methano-3,4,5,6-tetrahydro-2H-l-benzoxocin;
2,7-dihydroxy-5-isopropylidene-9-(n-heptyl)-
2,6-methano-3,4,5,6-tetrahydro-2H-1-benzoxocin;
2,7-dihydroxy-5-isopropylidene-9-(1-methylheptyl)-
2,6-methano-3,4,5,6-tetrahydro-2H-l-benzoxocin;
2,7-dihydroxy-5-isopropylidene-9-~1-cycloheptenyl)-
2,6-methano-3,4,5,6-tetrahydro-2H-l-benzoxocin; and
X-458CJ -7-

10~5062
2,7-dihydroxy-5-isopropylidene-9-(2-cyclooctenyl)-
2,6-methano-3,4,5,6-tetrahydro-2H-l-benzoxocin.
The l-alkoxy-4-(1-hydroxy-1-methylethyl)-1,4-
cyclohexadienes which are required as starting materials for
preparing the benzoxocin derivatives of the present in-
vention can readily be prepared by reducing p-alkoxy-
a,a-dimethylbenzyl alcohols. Typically, the reduction is
accomplished by reaction of the benzyl alcohol derivative
with a metal such as lithium in the presence of liquid
ammonia and a proton source such as ethyl alcohol. Such
reaction is carried out according to the standard Birch
reduction conditions. See Belgian Patent 856409. The
resorcinol starting compounds are readily available; see,
for example, Adams _ al., J. Am. Chem. Soc. 70, 664 (1948)._ _ _ _
The benzoxocin derivatives of formula I are useful
as intermediates in the synthesis of hexahydrodibenzopyranones.
The compounds of formula I are converted, upon treatment
with an aluminum halide such as aluminum chloride, to the
corresponding dl-trans-l-hydroxy-3-substituted-6,6-dimethyl-
20 6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-one. For
example, reaction of a 2-hydroxybenzoxocin of this invention,
such as 2,7-dihydroxy-5-isopropylidene-9-(1,2-dimethyl-
heptyl)-2,6-methano-3,4,5,6-tetrahydro-2H-l-benzoxocin, with
about a 2 to 4 molar excess of aluminum chloride in a
solvent such as dichloromethane effects rearrangement to
provide dl-trans-l-hydroxy-3-(1,2-dimethylheptyl)-6,6-
dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d~pyran-9-
one. Such dl-trans-hexahydrodibenzopyranones are useful in
the treatment of anxiety and depression, and are also
sedatives and analgesics.
X-4585J -8-

109SO~Z
The 2-hydroxybenzoxocins of formula I can also
be converted to the corresponding dl-cis-hexahydrodibenzo-
pyranone by additional treatment with stannic chloride. For
example, reaction of 5-isopropylidene-2,7-dihydroxy-9-
n-pentyl-2,6-methano-3,4,5,6-tetrahydro-2H-l-benzoxocin with
about an equimolar quantity or an excess of stannic chloride
in a solvent such as benzene effects rearrangement to
provide dl-cis-l-hydroxy-3-n-pentyl-6,6-dimethyl-6,6a,7,-
8,10,10a-hexahydro-9H-dibenzo[b,d]pyran 9-one. Such cis-
hexahydrodibenzopyranones, while pharmacologically active inthe treatment of anxiety and depression, are somewhat less
active than the corresponding trans-isomer. However,
treatment of such cls-hexahydrodibenzopyranones with an
aluminum halide such as aluminum chloride effects epimeriza-
tion to provide the corresponding pharmacologically more
active trans-hexahydrodibenzopyranone. For example,
reaction of dl-cis-1-hydroxy-3-n-pentyl-6,6-dimethyl-
6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-one with
aluminum chloride in dichloromethane effects epimerization
to provide the corresponding dl-trans-hexahydrodibenzo-
pyranone.
Example 1
2,7-Dihydroxy-5-isopropylidene-9-(1,1-dimethylheptyl)-2,6-
methano-3,4,5,6-tetrahydro-2~ benzoxocin
A solution of 11.8 g. of 5-(1,1-dimethylheptyl)-
resorcinol, 12.0 g. of 1-methoxy-4-(1-hydroxy-1-methyl-
ethyl)-1,4-cyclohexadiene and 0.9 ml. of water in 100 ml. of
dichloromethane stabilized with cyclohexane (ie. commercial
grade dichloromethane) was stirred and cooled to -20C. in a
dry ice-acetone bath. To the cold stirred solution was
X-4585J -9-
..

~so~z
added 13 ml. o~ stannic chloride dropwise at a rapid rate
over three minutes, during which time the temperature of the
reaction mixture increased to -11C. Immediately following
complete addition of the stannic chloride to the reaction
mixture, the mixture was poured into 2C0 9. of ice, and
50 ml. of water was added to the ice mixture. The organic
layer was separated, washed twice with 200 ml. portions of
1~ sodium hydroxide and th~n with 250 ml. of water. The
organic layer next was dried, and the solvent was removed by
evaporation under reduced pressure to provide 20.5 g. of the
product as a solid. The solid thus formed was recrystal-
lized from'n-hexane to afford 16.2 g. (87 percent yield) of
2,7-dihydroxy-5-isopropylidene-9-(1,1-dimethylheptyl)-2,6-
methano-3,4,5,6-tetrahydro-2H-l-benzoxocin. M.P. 148-152C.
Example 2
2,7-Dihydroxy-5-isopropylidene-9-~1,1-dimethylheptyl)-2,6-
methano-3,4,5,6-tetrahydro-2H-l-benzoxocin
A mixture of 11.8 g. of 5-(1,1-dimethylheptyl)-
resorcinol, 12.0 g. of l-methoxy-4-(l-hydroxy-l-methylethyl)
1,4-cyclohexadiene, 0.9 ml. of water and 100 ml. of di-
chloromethane was cooled to 0C. The mixture was stirred
while 13 ml. of stannic chloride was added dropwise over a
10 minute period, holding the temperature of the reaction
mixture between 0C. and 10C. The reaction mixture was
immediately worked up as described in Example 1, to obtain
15.5 y. of 2,7-dihydroxy-5-isopropylidene-9-(1,1-dimethyl-
heptyl)-2,6-methano-3,4,5,6 tetrahydro-2H-l-ben~oxocin, M.P.
145~148C., yield 83~.
X-~585 J -10-
~,
. ~ J~!

~ 95f)6~:
Example 3
2,7-Dihydroxy-5-isopropylidene-9-(1,1-dimethylheptyl)-2,6-
methano-3,4,5,6-tetrahydro-2H-l-benzoxocin
The process of Example 2 was carried out again,
except that the initial temperature of the reaction mixture
was -20C., and the stannic chloride was added over a time
of 2-3 minutes, while the reaction mixture was allowed to
warm to 9C. The mixture was worked up as described in
Example 1 to obtain 16.0 g. of 2,7-dihydroxy-5-isopropylidene-
9-(1,1-dimethylheptyl)-2,6-methano-3,4,5,6-tetrahydro-
2H-l-benzoxocin, M.P. 151-153C., yield 87~.
Examp~e 4
2,7-Dihydroxy-5-isopropylidene-9-(1,1-dimethylheptyl)-2,6-
methano-3,4,5,6-tetrahydro-2H-l-benzoxocin
The same process as Examples 2-3 was used in this
example, except that the initial temperature of the reaction
mixture was -40C. The stannic chloride was added in 1
minute, and the temperature of the reaction rose to -11C.
The same procedure of work up was used, to obtain a yield of
14.2 g. of 2,7-dihydroxy-5-isopropylidene-9-(1,1-dimethyl-
heptyl)-2,6-methano-3,4,5,6 tetrahydro-2H-l-benzoxocin, M.P.
153-155C., yield 78%.
Exam~le 5
2,7-Dihydroxy-5-isopropylidene-9-(1,1-dimethylheptyl)-2,6-
methano-3,4,5,6-tetrahydro-2H-l-benzoxocin
A 2.36 g. portion of 5-(1,1-dimethylheptyl)-
resorcinol and a 2.0 g. portion of 1-methoxy-4-(1-hydroxy~
l-methylethyl)-1,4-cyclohexadiene were combined in 25 ml. of
toluene, the solution was cooled to -20C., an 0.18 ml.
portion of water was added, and then 2.6 ml. of stannic
chloride was added in a period of 2 minutes, while the
X-4585J -11-

~)9506Z
temperature rose to -4C. The reaction mixture was im-
mediately worked up as described in Example 1 to obtain
1.47 g. of 2,7-dihydroxy-5-isopropylidene-9-(1,1-dimethyl-
heptyl)-2,6~methano-3,4,5,6-tetrahydro-2H-l-benzoxocin, M.P.
156-158C., yield 40%~
Preparation 1
dl-trans-l-hydroxy-3-(1,1-dimethylheptyl)-6,6-dimethyl-
6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-one
A solution of 100 mg. of 2,7-dihydroxy-5-iso-
propylidene-9-(1~1-dimethylheptyl)-2,6-methano-3,4,5,6-
tetrahydro-2H-l-benzoxocin in 5 ml. of dichloromethane was
stirred at about 24C. while 100 mg. of aluminum chloride
was added in one portion. The reaction mixture was stirred
at 24C. for six hours, and was then washed with lN hydro-
chloric acid solution, with water, and dried. Removal of
the solvent by evaporation under reduced pressure provided a
solid residue, which was recrystallized from hexane to
provide dl-trans-l-hydroxy-3-(1,1-dimethylheptyl)-6,6-
dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-
one. M.P. 160-161C.
X-4585J -12-

Representative Drawing

Sorry, the representative drawing for patent document number 1095062 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Inactive: Expired (old Act Patent) latest possible expiry date 1998-02-03
Grant by Issuance 1981-02-03

Abandonment History

There is no abandonment history.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
ELI LILLY AND COMPANY
Past Owners on Record
CHARLES W. RYAN
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 1994-03-08 1 12
Abstract 1994-03-08 1 13
Claims 1994-03-08 5 94
Drawings 1994-03-08 1 7
Descriptions 1994-03-08 11 353